Nutriband (NASDAQ:NTRB - Get Free Report) will likely be posting its quarterly earnings results before the market opens on Tuesday, April 29th. Analysts expect Nutriband to post earnings of ($0.12) per share and revenue of $0.71 million for the quarter.
Nutriband Price Performance
Shares of NTRB remained flat at $5.32 on Friday. The stock had a trading volume of 8,835 shares, compared to its average volume of 75,047. The firm has a market capitalization of $59.08 million, a P/E ratio of -7.49 and a beta of 1.19. The company has a quick ratio of 4.83, a current ratio of 4.96 and a debt-to-equity ratio of 0.01. Nutriband has a fifty-two week low of $3.30 and a fifty-two week high of $11.78. The business has a fifty day moving average price of $6.08 and a 200 day moving average price of $5.74.
Analyst Ratings Changes
Separately, Noble Financial started coverage on shares of Nutriband in a research report on Wednesday, January 22nd. They issued an "outperform" rating and a $13.00 price objective for the company.
Get Our Latest Stock Report on Nutriband
About Nutriband
(
Get Free Report)
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
See Also
Before you consider Nutriband, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutriband wasn't on the list.
While Nutriband currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
